These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9548395)

  • 1. Respiratory effects of halothane and AMPA receptor antagonist synergy in rats.
    Shimazu Y; Umemura K; Kawano K; Hokamura K; Kawazura H; Nakashima M
    Eur J Pharmacol; 1998 Jan; 342(2-3):261-5. PubMed ID: 9548395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of MK-801-induced breathing impairment by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    McManigle JE; Taveira DaSilva AM; Dretchen KL; Gillis RA
    Eur J Pharmacol; 1994 Jan; 252(1):11-7. PubMed ID: 8149990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel AMPA receptor antagonists: synthesis and structure-activity relationships of 1-hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H)- quinoxalinedione and related compounds.
    Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
    J Med Chem; 1996 Sep; 39(20):3971-9. PubMed ID: 8831762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of YM90K, a selective and potent antagonist of AMPA receptors, in rat cortical mRNA-injected Xenopus oocytes.
    Okada M; Kohara A; Yamaguchi T
    Eur J Pharmacol; 1996 Aug; 309(3):299-306. PubMed ID: 8874154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist and an N-methyl-D-aspartate (NMDA) channel blocker synergistically impair spatial memory in rats.
    Li H; Matsumoto K; Watanabe H
    Biol Pharm Bull; 1998 Nov; 21(11):1228-30. PubMed ID: 9853420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain.
    Nellgård B; Wieloch T
    Acta Physiol Scand; 1992 Dec; 146(4):497-503. PubMed ID: 1283483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excitatory amino acid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopamine-lesioned rats.
    Engber TM; Anderson JJ; Boldry RC; Papa SM; Kuo S; Chase TN
    Neuroscience; 1994 Mar; 59(2):389-99. PubMed ID: 8008198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
    Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T
    Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists.
    Papa SM; Engber TM; Boldry RC; Chase TN
    Eur J Pharmacol; 1993 Mar; 232(2-3):247-53. PubMed ID: 8385618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-alpha]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor.
    Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
    J Med Chem; 1997 Jun; 40(13):2053-63. PubMed ID: 9207947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats.
    Suzuki Y; Takagi Y; Nakamura R; Hashimoto K; Umemura K
    Brain Res; 2003 Feb; 964(1):116-20. PubMed ID: 12573519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
    Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
    Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
    Xu XJ; Hao JX; Seiger A; Wiesenfeld-Hallin Z
    J Pharmacol Exp Ther; 1993 Oct; 267(1):140-4. PubMed ID: 8229741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPA receptor competitive antagonism reduces halothane MAC in rats.
    McFarlane C; Warner DS; Todd MM; Nordholm L
    Anesthesiology; 1992 Dec; 77(6):1165-70. PubMed ID: 1334638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presynaptic and postsynaptic actions of halothane at glutamatergic synapses in the mouse hippocampus.
    Kirson ED; Yaari Y; Perouansky M
    Br J Pharmacol; 1998 Aug; 124(8):1607-14. PubMed ID: 9756375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists.
    Maj J; Rogóz Z; Skuza G; Jaros T
    Pol J Pharmacol; 1995; 47(4):269-77. PubMed ID: 8616504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: structure-activity relationships for the AMPA-type non-NMDA receptor.
    Ohmori J; Sakamoto S; Kubota H; Shimizu-Sasamata M; Okada M; Kawasaki S; Hidaka K; Togami J; Furuya T; Murase K
    J Med Chem; 1994 Feb; 37(4):467-75. PubMed ID: 8120865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-additive protective effect of dizocilpine and NBQX against neuronal damage.
    Lippert K; Welsch M; Krieglstein J
    Eur J Pharmacol; 1994 Mar; 253(3):207-13. PubMed ID: 7911083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.